Health News Archive - May 10, 2010
WELLINGTON, Fla., May 10 /PRNewswire-USNewswire/ -- Dr. Richard Hays announced today that he is now recruiting children with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial.
SHENZHEN, China, May 10 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) announces that the company successfully acquired the first contract for its Freeze-dried Varicella Vaccine. After the HTDS acquired Approval for its Freeze-dried MEVAC-vari in this Central American country (company's first Varicella vaccine approval in Latin America), the company closed the first contract in Guatemala and expects to ship and deliver its vaccine in May. A source close to the company stated, "We are thrilled to close our first deal in less than two months after the final ministry approval.
A study by researchers from the Georgetown Lombardi Comprehensive Cancer Center at Georgetown University Medical Center (GUMC) identifies a potential new combination therapy to "rescue" treatment sensitivity to fulvestrant in estrogen receptor positive breast cancers.
Amodiaquine was introduced as an antimalarial drug, but was withdrawn when serious adverse effects were observed.
Recent decades have seen a huge increase in type 2 diabetes and cardiovascular disease.
ROCHESTER, N.Y., May 10 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSCP), a leading provider of quantitative imaging for clinical trials, announced today that Ms.
LOVELAND, Colo., May 10 /PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq: HSKA) today announced it will present at the SunTrust Robinson Humphrey 1st Annual Veterinary Conference on Wednesday, May 12, 2010.
NEW YORK, May 10 /PRNewswire/ -- MoleSafe (www.molesafe.com), a novel, state-of-the-art melanoma screening program, has begun providing services at the Charles C. Harris Skin and Cancer Pavilion in the Ronald O. Perelman Department of Dermatology at NYU Langone Medical Center.
ARDEE, Ireland, May 10 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 11, 2010 at 8:00 a.m. EDT.
- A person in a secondary role, specifically the second most important character (after the protagonist).